NYSE: CTVA · Industrial Applications and Services · 16 alerts · CIK 1755672
Share price
$9.04Close, Nov 16
Market cap
$6.03B
Shares outstanding
667.32MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Agricultural Production-CropsSIC 0100
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Corteva, Inc. filings on SEC EDGAR ↗
Corteva Director Gregory R. Page Buys $185K of Stock
Gregory R. Page, Director, bought 20,000 shares of Corteva, Inc. at $9.25 to $9.29 a share (average $9.27) in 2 transactions, worth $185K in total between Nov 13, 2026 and Nov 16, 2026. Shares held after the trade: 20,000 (+100.0%).
Corteva CEO Luther C. Kissam IV Buys $300K of Stock
Luther C. Kissam IV, CEO, bought 32,292 shares of Corteva, Inc. at $9.30 a share, worth $300K in total on Nov 13, 2026. Shares held after the trade: 185,379 (+21.1%).
Corteva, Inc. filed combined financial statements for 'New Corteva' (its Crop Protection Business) following the October 1, 2026, spin-off of its Seed Business into Vylor Inc. The filing provides historical and interim financial results for the three and nine months ended September 30, 2026, reflecting the new corporate structure where Vylor is treated as the accounting successor.
For the nine months ended September 30, 2026, Corteva reported net sales of $13,742 million, a slight increase from $13,491 million in the prior year. However, net income attributable to Corteva decreased to $1,311 million compared to $1,646 million in 2025, primarily driven by higher separation costs and a loss from continuing operations in the third quarter. The company also completed the separation of its Seed business (Vylor) on October 1, 2026.
Corteva reported third-quarter 2026 financial results, with net sales of $1.59 billion, a 9% decrease compared to the prior year. The company updated its full-year 2026 guidance, lowering expectations due to weaker market conditions in Brazil and pricing pressure on older molecules.
“We executed well against the things we can control. New products performed strongly, productivity delivered, and we generated broad-based organic growth outside Latin America. The pressure remains concentrated. Acetochlor pricing in the U.S. was consistent with our expectations, but Brazil was materially weaker than anticipated. While those conditions are reflected in our updated outlook, our strategy has not changed. Innovation, productivity and disciplined execution remain the foundation for sustainable long-term growth.”